Wednesday, May 16, 2012

Manchester College executive vice president will lead School of Pharmacy.

Ending a nationwide search, Manchester College in North Manchester, Ind., is turning to executive vice president Dave McFadden as its new dean for the School of Pharmacy. McFadden, who was influential in establishment of the professional Doctor of Pharmacy program in Fort Wayne, Ind., has served as interim dean for five months. Founding dean Phil Medon resigned in November for health reasons.

“Dave was at the forefront in our thinking and planning for the Pharmacy School and has immersed himself in learning about pharmacy for the past five years,” said president Jo Young Switzer in announcing the appointment, effective May 4. “He worked with the core team that developed the successful $35 million grant proposal for the School of Pharmacy to Lilly Endowment Inc.”

Pharmacy classes begin Aug. 13 on the new campus in north Fort Wayne. Working from a national pool of 470 applicants, Manchester is close to filling its first class of 70 students for the four-year program.

McFadden has more than 20 years of higher education leadership experience. At Manchester, he has led enrollment, strategic planning, and marketing initiatives, as well as the name change to Manchester University scheduled for July 1. He has served as interim dean of academic affairs and assistant professor of political science. He is a 1982 graduate of Manchester College and holds a Ph.D. from Claremont (Calif.) Graduate School.

A search committee reviewed a strong pool of applicants and brought two finalists to the campuses. Afterward, both the committee and Manchester’s national pharmacy consultant recommended McFadden for the position. McFadden will continue as executive vice president, retaining an office on the North Manchester campus but spending the majority of his time in Fort Wayne. For more about the Manchester School of Pharmacy, visit

-- Jeri S. Kornegay is director of Media and Public Relations for Manchester College.

Source:5/16/2012 Newsline

No comments: